Rohit Jain, MD Profile
Rohit Jain, MD

@rohitjainMD

Followers
267
Following
103
Statuses
64

GU Medical Oncologist @ Weill Cornell Medicine

New York, USA
Joined June 2019
Don't wanna be here? Send us removal request.
@rohitjainMD
Rohit Jain, MD
8 months
RT @rutikamehtaMD: Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers ht…
0
3
0
@rohitjainMD
Rohit Jain, MD
8 months
@LaurenMachos Congratulations Lauren
1
0
1
@rohitjainMD
Rohit Jain, MD
9 months
RT @VJOncology: May is #BladderCancerAwarenessMonth 📣 And we are passionate about bringing you the latest news and updates 🎥 🗞️ @rohitj
0
1
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @ASCOPost: Rohit K. Jain, MD, MPH, on Urothelial Carcinoma: New Data on Cabozantinib Plus Pembrolizumab #blcsm #…
Tweet media one
0
5
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @GUOncologyNow: A study from @rohitjainMD and colleagues presented at #GU24 showed that #cabozantinib plus #pembrolizumab exhibited a ma…
0
1
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @OncLive: First-line pembrolizumab plus cabozantinib was efficacious and had a manageable toxicity profile in patients with advanced uro…
0
2
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @OncLive: Pembrolizumab plus cabozantinib was efficacious in the first-line treatment of patients with cisplatin-ineligible urothelial c…
0
2
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @sonpavde: #GU24 #bladdercancer highlights in my opinion: 1) AMBASSADOR Phase III @apolo_andrea-improved DFS for adjuvant pembro x 1 yea…
0
34
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @urotoday: Phase Ib trial of erdafitinib combined with enfortumab vedotin following platinum and PD-1/L1 inhibitors for metastatic #Urot
0
7
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @sonpavde: #GU24 #bladdercancer #urothelialcarcinoma preview: PemCab Phse II #clinicaltrial- Cabozantinib + pembrolizumab as first-line…
0
9
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @neerajaiims: Just in @NatureMedicine👉Results from Ph3 TALAPRO-2 trial in 399 pts w/ HRR-deficient mCRPC #prostatecancer👉enza + tala vs.…
0
107
0
@rohitjainMD
Rohit Jain, MD
1 year
RT @CancerNetwrk: When Jeffrey Ehas was diagnosed with cancer, he and his wife, Lauren Ehas, turned to Moffitt Cancer Center in Tampa, Flor…
0
1
0
@rohitjainMD
Rohit Jain, MD
2 years
RT @FDavaro: Read our mini-article on what a urologist needs to know in the management of ICU related AEs in NMIBC. Critical for urologists…
0
5
0
@rohitjainMD
Rohit Jain, MD
2 years
RT @sonpavde: Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets…
0
6
0
@rohitjainMD
Rohit Jain, MD
2 years
RT @OncLive: WATCH: Rutika Mehta, MD, MPH, discusses which pts w/ ESCC may benefit most from the different frontline treatment options avai…
0
1
0
@rohitjainMD
Rohit Jain, MD
3 years
RT @Jcj84Jeremy: Dr Mehta giving updates in gastroesophageal cancer at the 1st annual Highlights in GI Oncology. @drjasonstarr @HaniBabiker
0
3
0
@rohitjainMD
Rohit Jain, MD
3 years
RT @AbhiTrip87: @montypal @NazliDizman @LuisMezaco @PauloBergerot @TGen @cityofhope @montypal What an inspiring thread for all young invest…
0
3
0
@rohitjainMD
Rohit Jain, MD
3 years
RT @FrontOncology: 📣 Check out this report of chemo refractory metastatic penile SCC with extreme durable response to pembrolizumab by @Jad
0
7
0
@rohitjainMD
Rohit Jain, MD
3 years
RT @Dr_M_Tejani: Come learn and discuss with us the latest in GI Oncology! Excellent speakers including @HaniBabiker @drjasonstarr @rutikam
0
6
0